Nov 19 (Reuters) - EXINI Diagnostics AB EXIN.ST
* EXINI enters collaboration with DexTech Medical AB
* Says has signed a collaboration agreement with DexTech as
to a clinical phase-II study with the candidate drug OsteoDex
* Objective is to monitor the progression of bone-metastatic
disease in castration-resistant prostate cancer patients,
utilizing the software package EXINI boneBSI in a clinical
phase-II study of a new drug compound against bone
metastases
Source text for Eikon: ID:nSSN5zNW
Further company coverage: EXIN.ST
(gdynia.newsroom@thomsonreuters.com; +48 58 698 3920)
Keywords: EXINI/BRIEF